🇺🇸 FDA
Patent

US 8188214

Brachyury polypeptides and methods for use

granted A61KA61K2039/53A61K39/00

Quick answer

US patent 8188214 (Brachyury polypeptides and methods for use) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue May 29 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
42
CPC classes
A61K, A61K2039/53, A61K39/00, A61K40/11, A61K40/42